Role of antibiotic prophylaxis in antenatal hydronephrosis: A systematic review from the European Association of Urology/European Society for Paediatric Urology Guidelines Panel

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F17%3A10364408" target="_blank" >RIV/00216208:11110/17:10364408 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00064165:_____/17:10364408

Výsledek na webu

<a href="http://dx.doi.org/10.1016/j.jpurol.2017.02.023" target="_blank" >http://dx.doi.org/10.1016/j.jpurol.2017.02.023</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1016/j.jpurol.2017.02.023" target="_blank" >10.1016/j.jpurol.2017.02.023</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Role of antibiotic prophylaxis in antenatal hydronephrosis: A systematic review from the European Association of Urology/European Society for Paediatric Urology Guidelines Panel

Popis výsledku v původním jazyce

The review aims to compare benefits and harms of continuous antibiotic prophylaxis (CAP) with observation in patients with antenatal hydronephrosis. The search was performed in databases - Medline, Embase, Cochrane - since 1980 and the studies were critically evaluated using Revman software. The outcomes included reduction in urinary tract infection (UTI), drug related adverse events and kidney function. 57 from 797 articles and six abstracts were eligible for inclusion. The benefit of CAP in a heterogeneous group of children with antenatal hydronephrosis involving different etiologies remains unproven. No conclusion could be drawn for drug-related adverse events and kidney function. However, the evidence from the prospective and retrospective studies has shown that CAP reduces febrile UTI in particular subgroups: non-circumcised children, children with ureteral dilatation and with high-grade hydronephrosis.

Název v anglickém jazyce

Role of antibiotic prophylaxis in antenatal hydronephrosis: A systematic review from the European Association of Urology/European Society for Paediatric Urology Guidelines Panel

Popis výsledku anglicky

The review aims to compare benefits and harms of continuous antibiotic prophylaxis (CAP) with observation in patients with antenatal hydronephrosis. The search was performed in databases - Medline, Embase, Cochrane - since 1980 and the studies were critically evaluated using Revman software. The outcomes included reduction in urinary tract infection (UTI), drug related adverse events and kidney function. 57 from 797 articles and six abstracts were eligible for inclusion. The benefit of CAP in a heterogeneous group of children with antenatal hydronephrosis involving different etiologies remains unproven. No conclusion could be drawn for drug-related adverse events and kidney function. However, the evidence from the prospective and retrospective studies has shown that CAP reduces febrile UTI in particular subgroups: non-circumcised children, children with ureteral dilatation and with high-grade hydronephrosis.

Druh

J_imp - Článek v periodiku v databázi Web of Science

CEP obor

—

OECD FORD obor

30217 - Urology and nephrology

Projekt

—

Návaznosti

V - Vyzkumna aktivita podporovana z jinych verejnych zdroju

Rok uplatnění

2017

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Journal of Pediatric Urology

ISSN

1477-5131

e-ISSN

—

Svazek periodika

13

Číslo periodika v rámci svazku

3

Stát vydavatele periodika

GB - Spojené království Velké Británie a Severního Irska

Počet stran výsledku

10

Strana od-do

306-315

Kód UT WoS článku

000406687000041

EID výsledku v databázi Scopus

2-s2.0-85018836803